Why Nike Shares Are Sinking Today

Nike downgraded by Oppenheimer analyst, amid the company's plan to cut 1,600 jobs to save costs. The analyst expects top-line trends at the enterprise to remain sluggish and below algo in the next several quarters.

Oppenheimer analyst downgraded Nike Inc (NYSE:NKE) to Perform from Outperform and lowered the price target to $110 (from $150). 

Also, the company reportedly plans to reduce over 1,600 jobs to enhance focus on key categories like running and women’s apparel.

This is at par with the company’s aim to deliver up to $2 billion in cumulative cost savings during the next three years.

The analyst expects top-line trends at the enterprise to remain sluggish and below algo in the next several quarters.

The analyst cited several concerns, including spotty consumer demand, pauses in product innovation, and modest competitive incursions in select categories. 

For the third quarter (Feb), the analyst lowered EPS estimates to $0.74 (from $0.96) vs. consensus of $0.76, with currency-adjusted revenue growth projected to be down 0.7% (from +5% earlier). 

For FY26 (May), the analyst cut EPS estimates to $4.57 (from $5.20) vs. consensus of $4.95 and expects currency-adjusted sales expansion of +5%-7%. 

Price Action: NKE shares are trading lower by 3% at $102.87 on the last check Friday.

Image: Shutterstock/ pio3

Total
0
Shares
Related Posts
Read More

Over $1M Bet On This Basic Materials Stock? Check Out These 4 Penny Stocks Insiders Are Aggressively Buying

The Dow Jones closed slightly lower on Friday. When insiders purchase or sell shares, it indicates their confidence or concern around the company's prospects. Investors and traders interested in penny stocks can consider this a factor in their overall investment or trading decision.

INKT

Read More

CRISPR Therapeutics Announces Leadership Transition; Co-Founder, Rodger Novak, M.D., To Step Down As President And Chairman; CEO Samarth Kulkarni, Ph.D., To Succeed Dr. Novak As Chairman Effective September 15, 2023

-CRISPR Therapeutics co-founder, Rodger Novak, M.D., to step down as President and Chairman, effective September 15, 2023- -Samarth Kulkarni, Ph.D., to succeed Dr. Novak as Chairman and will continue serving as CEO of

CRSP

Read More

Janet Jackson Gets Concert Date Moved Due To Atlanta Hawks Sticking Around In The NBA Playoffs, Guess ‘That’s The Way Love Goes’

Owning a sports arena that can host sports matches and concerts often has a delicate balance of scheduling to make sure events are not double-booked. One NBA team saw their arena schedule dates for concerts in the month of April, which is when the NBA Playoffs take place. Was the arena hoping for the team to not make the NBA Playoffs?

DKNG